Home » Topics » Collaboration, BioWorld Science

Collaboration, BioWorld Science
RSS

Eisai and Helsinn enter license agreement for antiemetic combination agent

June 10, 2010

Vivalis and Sanofi Pasteur join to discover MAbs for infectious diseases

June 10, 2010

TransTech and Forest enter into agreement to develop GKAs

June 10, 2010

Opal Therapeutics and MGH to jointly develop HIV vaccine

June 9, 2010

Immunovaccine and Vaxil join to advance potential cancer vaccine

June 9, 2010

AVI BioPharma and DTRA enter into new contract for AVI-7100

June 9, 2010

TauRx and Bayer Schering enter into AD collaboration

June 8, 2010

Scancell and ImmuneRegen BioSciences form strategic alliance

June 8, 2010

Ascenta and sanofi-aventis sign license agreement in oncology

June 8, 2010

Intercell partners with Inclinix for phase III trial of travelers' diarrhea vaccine

June 7, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...